• For Individuals
  • For Institutions
  • Download
  • Help

  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文（廣東話）Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials

Event Tracking

Nov18
CITIC Securities Maintains Buy Rating on Noego and Sets Target Price
05:12
Company Responds to Investor Inquiries on Drug R&D and Sales Progress
01:33
Nov17
UBS Adjusts Nomura Cansa Health Target Price to 23.6 HKD
08:42
Nov14
InnoCare Pharma Reports Strong Q3 2025 Revenue Growth, Orelabrutinib Sales Surge
11:02
Nov13
InnoCare Pharma released FY2025 9 Months Earnings on November 13 After-Market (BJT), with actual revenue of CNY 1.115 B and EPS of CNY -0.0484
01:00
InnoCare Pharma released FY2025 Q3 earnings on November 13 After-Market (BJT), actual revenue CNY 383.89 M (forecast CNY 382.61 M), actual EPS CNY -0.0188 (forecast CNY -0.02)
01:00

Schedules & Filings

Schedules
Filings
Nov13
Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 383.89 M, Net Income -34.32 M, EPS -0.0188

Aug19
Earning Release(CST)

FY2025 Q2 Earning Release (CNY) Revenue 350.17 M, Net Income -48.06 M, EPS -0.0396

May13
Earning Release(CST)

FY2025 Q1 Earning Release (CNY) Revenue 381.26 M, Net Income 17.97 M, EPS 0.01

View More

Stock List

Top Gainers
Top Decliners
Northbound Connect
Symbol
Price
%Chg
Change
View More
Terms & Conditions
  • Terms of Service
  • Privacy Policy